• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干粉吸入器:含有硫酸沙丁胺醇的乳糖配方的机械评估。

Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.

机构信息

Chemistry and Drug Delivery Group, Medway School of Pharmacy, University of Kent, ME4 4TB Kent, UK.

出版信息

Int J Pharm. 2012 Feb 28;423(2):184-94. doi: 10.1016/j.ijpharm.2011.12.018. Epub 2011 Dec 17.

DOI:10.1016/j.ijpharm.2011.12.018
PMID:22197772
Abstract

The purpose of this study was to evaluate the relationships between physicochemical properties and aerosolisation performance of different grades of lactose. In order to get a wide range of physicochemical properties, various grades of lactose namely Flowlac 100 (FLO), Lactopress anhydrous 250 (LAC), Cellactose 80 (CEL), Tablettose 80 (TAB), and Granulac 200 (GRA) were used. The different lactose grades were carefully sieved to separate 63-90 μm particle size fractions and then characterised in terms of size, shape, density, flowability, and solid state. Formulations were prepared by blending each lactose with salbutamol sulphate (SS) at ratio of 67.5:1 (w/w), and then evaluated in terms of SS content uniformity, lactose-SS adhesion properties, and in vitro aerosolisation performance delivered from the Aerolizer. Sieved lactose grades showed similar particle size distributions (PSDs) and good flow properties but different particle shape, particle surface texture, and particle solid state. Content uniformity assessments indicated that lactose particles with rougher surface produced improved SS homogeneity within DPI formulation powders. Lactose-SS adhesion assessments indicated that lactose particles with more elongated shape and the rougher surface showed smaller adhesion force between lactose and salbutamol sulphate. Lactose powders with higher bulk density and higher tap density produced smaller emission (EM) and higher drug loss (DL) of SS. In vitro aerosolisation for various lactose grades followed the following rank order in terms of deposition performance: GRA>TAB>LAC ≈ CEL>FLO. Linear relationships were established showing that in order to maximize SS delivery to lower airway regions, lactose particles with more elongated shape, more irregular shape, and rougher surface are preferred. Therefore, considerable improvement in DPI performance can be achieved by careful selection of grade of lactose included within DPI formulations.

摘要

本研究旨在评估不同等级乳糖的物理化学性质与气溶胶化性能之间的关系。为了获得广泛的物理化学性质,使用了各种等级的乳糖,即 Flowlac 100(FLO)、Lactopress 无水 250(LAC)、Cellactose 80(CEL)、Tablettose 80(TAB)和 Granulac 200(GRA)。将不同等级的乳糖仔细过筛,分离出 63-90μm 的粒径级分,然后在粒径、形状、密度、流动性和固体状态方面进行表征。将每种乳糖与硫酸沙丁胺醇(SS)按 67.5:1(w/w)的比例混合制成制剂,然后从 Aerolizer 评估 SS 含量均匀性、乳糖-SS 粘附特性和体外气溶胶化性能。过筛的乳糖等级具有相似的粒径分布(PSD)和良好的流动性,但具有不同的颗粒形状、颗粒表面纹理和颗粒固体状态。含量均匀性评估表明,表面较粗糙的乳糖颗粒可提高 DPI 制剂粉末中 SS 的均匀度。乳糖-SS 粘附评估表明,形状更细长、表面更粗糙的乳糖颗粒之间的粘附力较小。具有较高堆密度和较高振实密度的乳糖粉末会导致 SS 的发射(EM)更小,药物损失(DL)更高。各种乳糖等级的体外气溶胶化性能以下列沉积性能顺序排列:GRA>TAB>LAC≈CEL>FLO。建立了线性关系,表明为了将 SS 最大程度地输送到下呼吸道区域,更细长、更不规则形状和更粗糙的乳糖颗粒是优选的。因此,通过仔细选择包含在 DPI 制剂中的乳糖等级,可以显著提高 DPI 的性能。

相似文献

1
Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.干粉吸入器:含有硫酸沙丁胺醇的乳糖配方的机械评估。
Int J Pharm. 2012 Feb 28;423(2):184-94. doi: 10.1016/j.ijpharm.2011.12.018. Epub 2011 Dec 17.
2
The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.结晶乳糖的物理性质和形态对硫酸沙丁胺醇干粉吸入剂释药的影响。
Colloids Surf B Biointerfaces. 2012 Jan 1;89:29-39. doi: 10.1016/j.colsurfb.2011.08.019. Epub 2011 Sep 10.
3
Effect of carrier particle shape on dry powder inhaler performance.载体颗粒形状对干粉吸入器性能的影响。
Int J Pharm. 2011 Dec 12;421(1):12-23. doi: 10.1016/j.ijpharm.2011.09.010. Epub 2011 Sep 17.
4
Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.湿度引起的含有不同载体的干粉气雾剂制剂空气动力学性质的变化。
Int J Pharm. 2007 Mar 21;333(1-2):45-55. doi: 10.1016/j.ijpharm.2006.09.048. Epub 2006 Oct 1.
5
Antisolvent crystallisation is a potential technique to prepare engineered lactose with promising aerosolisation properties: effect of saturation degree.抗溶剂结晶法是一种具有潜在应用前景的技术,可用于制备具有良好空气动力学性质的工程化乳糖:饱和度的影响。
Int J Pharm. 2012 Nov 1;437(1-2):57-69. doi: 10.1016/j.ijpharm.2012.07.064. Epub 2012 Aug 4.
6
Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.用乙醇-丙酮二元混合物结晶得到的乳糖制备硫酸沙丁胺醇,可改善其气溶胶化性能。
J Pharm Sci. 2011 Jul;100(7):2665-84. doi: 10.1002/jps.22483. Epub 2011 Jan 25.
7
Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.干粉吸入器:一种有前景的替代载体——冻干甘露醇的几个粒径级分的物理化学性质和气溶胶化特性
Eur J Pharm Sci. 2015 Feb 20;68:56-67. doi: 10.1016/j.ejps.2014.12.005. Epub 2014 Dec 9.
8
Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.利用实验设计了解乳糖粒径对干粉吸入剂制剂性质的影响。
Int J Pharm. 2009 Oct 1;380(1-2):80-8. doi: 10.1016/j.ijpharm.2009.07.002. Epub 2009 Jul 9.
9
Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.用于测定雾化粉末制剂粒度的激光衍射方法的开发。
Int J Pharm. 2006 Dec 1;326(1-2):39-49. doi: 10.1016/j.ijpharm.2006.07.021. Epub 2006 Jul 16.
10
Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.粒状乳糖作为干粉吸入剂制剂载体的评价1:颗粒大小的影响。
AAPS PharmSciTech. 2014 Dec;15(6):1417-28. doi: 10.1208/s12249-014-0166-z. Epub 2014 Jun 25.

引用本文的文献

1
Optimization of Carrier-Based Dry Powder Inhaler Performance: A Review.基于载体的干粉吸入器性能优化:综述
Pharmaceutics. 2025 Jan 13;17(1):96. doi: 10.3390/pharmaceutics17010096.
2
Different Carriers for Use in Dry Powder Inhalers: Characteristics of Their Particles.干粉吸入器中使用的不同载体:其颗粒特性
J Aerosol Med Pulm Drug Deliv. 2024 Dec;37(6):307-327. doi: 10.1089/jamp.2023.0029. Epub 2024 Aug 9.
3
The Optimisation of Carrier Selection in Dry Powder Inhaler Formulation and the Role of Surface Energetics.干粉吸入剂配方中载体选择的优化及表面能的作用
Biomedicines. 2022 Oct 26;10(11):2707. doi: 10.3390/biomedicines10112707.
4
Design and Characterization of Atorvastatin Dry Powder Formulation as a potential Lung Cancer Treatment.阿托伐他汀干粉制剂作为潜在肺癌治疗药物的设计与表征
Saudi Pharm J. 2021 Dec;29(12):1449-1457. doi: 10.1016/j.jsps.2021.11.002. Epub 2021 Nov 11.
5
Chitosan-based binary dry powder inhaler carrier with nanometer roughness for improving in vitro and in vivo aerosolization performance.壳聚糖基二元干粉末吸入器载体具有纳米粗糙度,可改善体外和体内气溶胶化性能。
Drug Deliv Transl Res. 2018 Oct;8(5):1274-1288. doi: 10.1007/s13346-018-0564-y.
6
Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.聚集新型喷雾干燥乳糖-亮氨酸作为载体,以提高 DPI 制剂中硫酸沙丁胺醇的空气动力学性能。
Drug Deliv Transl Res. 2018 Dec;8(6):1769-1780. doi: 10.1007/s13346-017-0462-8.
7
Influence of physical properties of carrier on the performance of dry powder inhalers.载体物理性质对干粉吸入器性能的影响。
Acta Pharm Sin B. 2016 Jul;6(4):308-18. doi: 10.1016/j.apsb.2016.03.011. Epub 2016 May 4.
8
Empirical modeling of the fine particle fraction for carrier-based pulmonary delivery formulations.基于载体的肺部给药制剂细颗粒部分的经验建模。
Int J Nanomedicine. 2015 Jan 21;10:801-10. doi: 10.2147/IJN.S75758. eCollection 2015.
9
Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.研制更理想的干粉吸入剂配方:大喷雾干燥甘露醇微球优于小微球。
Pharm Res. 2014 Jan;31(1):60-76. doi: 10.1007/s11095-013-1132-2. Epub 2013 Aug 6.
10
Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.冷冻干燥甘露醇干粉吸入剂用于改善肺部药物传递。
Pharm Res. 2013 Feb;30(2):458-77. doi: 10.1007/s11095-012-0892-4. Epub 2012 Oct 16.